way 123398 has been researched along with ly 97241 in 1 studies
| Studies (way 123398) | Trials (way 123398) | Recent Studies (post-2010) (way 123398) | Studies (ly 97241) | Trials (ly 97241) | Recent Studies (post-2010) (ly 97241) |
|---|---|---|---|---|---|
| 15 | 0 | 1 | 11 | 0 | 1 |
| Protein | Taxonomy | way 123398 (IC50) | ly 97241 (IC50) |
|---|---|---|---|
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.0061 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Finlayson, K; January, CT; Kelly, JS; Sharkey, J; Turnbull, L | 1 |
1 other study(ies) available for way 123398 and ly 97241
| Article | Year |
|---|---|
[3H]dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen.
Topics: Anti-Arrhythmia Agents; Benzimidazoles; Binding, Competitive; Cation Transport Proteins; Cell Line; Cell Membrane; DNA-Binding Proteins; Drug Evaluation, Preclinical; Electrocardiography; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Haloperidol; Humans; Patch-Clamp Techniques; Phenethylamines; Pimozide; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quaternary Ammonium Compounds; Sulfanilamides; Sulfonamides; Terfenadine; Trans-Activators; Transcriptional Regulator ERG; Transfection; Tritium | 2001 |